Montai: Mapping chem-bio connections to find human-vetted therapies

With a core thesis that molecules long consumed by humans contain starting points for safe, targeted oral medicines, Montai has built a computational platform to screen that diverse molecular universe for hits with desired bioactivity.

“We start with chemistries prequalified as safe,” Montai Therapeutics Inc. co-founder CEO Margo Georgiadis told BioCentury. “These are things that have been in our bodies for thousands of years, and already interact with our biological pathways.”...